In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...